Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers.
暂无分享,去创建一个
M. Espié | C. Sotiriou | C. Desmedt | M. Piccart | L. Pusztai | F. André | W. Symmans | M. Marty | S. Giacchetti | C. Mazouni | J. Lehmann-Che | H. de Thé | E. Turpin | P. Bertheau | L. Plassa